135 related articles for article (PubMed ID: 8002215)
21. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
Sasaki K; Hamano K; Kinjo M; Hara S
Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
[TBL] [Abstract][Full Text] [Related]
22. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
[TBL] [Abstract][Full Text] [Related]
23. Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.
Yokogi H; Wada Y; Moriyama-Gonda N; Igawa M; Ishibe T
Br J Urol; 1996 Nov; 78(5):699-703. PubMed ID: 8976763
[TBL] [Abstract][Full Text] [Related]
24. Flow cytofluorometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours.
Dyson JE; Joslin CA; Rothwell RI; Quirke P; Khoury GG; Bird CC
Radiother Oncol; 1987 Mar; 8(3):263-72. PubMed ID: 3575788
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous renal and transitional cell carcinomas in same kidney with subsequent lymph node metastasis: DNA flow cytometric study.
el-Naggar A; Ro JY; Sella A; Ayala AG
Urology; 1991 Dec; 38(6):585-8. PubMed ID: 1746094
[TBL] [Abstract][Full Text] [Related]
26. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
27. DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.
Gustafson H; Tribukait B; Esposti PL
Scand J Urol Nephrol; 1982; 16(2):135-9. PubMed ID: 7123163
[TBL] [Abstract][Full Text] [Related]
28. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493
[TBL] [Abstract][Full Text] [Related]
29. TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy.
Røtterud R; Skomedal H; Berner A; Danielsen HE; Skovlund E; Fosså SD
Acta Oncol; 2001; 40(5):644-52. PubMed ID: 11669339
[TBL] [Abstract][Full Text] [Related]
30. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
[TBL] [Abstract][Full Text] [Related]
31. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.
Tribukait B; Gustafson H; Esposti PL
Br J Urol; 1982 Apr; 54(2):130-5. PubMed ID: 7082931
[TBL] [Abstract][Full Text] [Related]
32. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
Wang Z
Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
[TBL] [Abstract][Full Text] [Related]
33. Deoxyribonucleic acid measurements in transitional cell carcinomas: comparison of flow and image cytometry techniques.
Goulandris N; Karakitsos P; Georgoulakis J; Bellos C; Deliveliotis C; Legaki S
J Urol; 1996 Sep; 156(3):958-60. PubMed ID: 8709372
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric DNA/cytokeratin analysis of bladder lavage: methodical aspects and clinical implications.
Liedl T
Urol Int; 1995; 54(1):22-47. PubMed ID: 7770998
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
[TBL] [Abstract][Full Text] [Related]
36. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder.
Fossä SD
Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320
[TBL] [Abstract][Full Text] [Related]
37. Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Berner A; Jacobsen AB; Fosså SD; Nesland JM
Histopathology; 1993 Apr; 22(4):327-33. PubMed ID: 8099896
[TBL] [Abstract][Full Text] [Related]
38. Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study.
Rew DA; Thomas DJ; Coptcoat M; Wilson GD
Br J Urol; 1991 Jul; 68(1):44-8. PubMed ID: 1873691
[TBL] [Abstract][Full Text] [Related]
39. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
